Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H19NO2 |
| Molecular Weight | 281.349 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCC\C=C(/C1=CC=CC=C1)C2=CC=CN=C2
InChI
InChIKey=UWPBQLKEHGGKKD-GZTJUZNOSA-N
InChI=1S/C18H19NO2/c20-18(21)12-6-2-5-11-17(15-8-3-1-4-9-15)16-10-7-13-19-14-16/h1,3-4,7-11,13-14H,2,5-6,12H2,(H,20,21)/b17-11+
| Molecular Formula | C18H19NO2 |
| Molecular Weight | 281.349 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Randomized trial of a selective inhibitor of thromboxane A2 synthetase, (E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151), for prevention of restenosis after coronary angioplasty. | 1991-04 |
|
| Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridylalkenoic acids. | 1985-03 |
|
| (E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor. | 1985 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:13:16 GMT 2025
by
admin
on
Mon Mar 31 18:13:16 GMT 2025
|
| Record UNII |
HGB7P08R36
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5284442
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
6299
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL28196
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
C77583
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
DTXSID4021133
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
SUB08307MIG
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
m780
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | Merck Index | ||
|
C045446
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
89667-40-3
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
HGB7P08R36
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY | |||
|
100000083380
Created by
admin on Mon Mar 31 18:13:16 GMT 2025 , Edited by admin on Mon Mar 31 18:13:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |